| Bioactivity | AChE-IN-27 (compound 8c) is an AChE inhibitor (IC50=0.19 µM). AChE-IN-27 can be used in studies of neurological diseases such as alzheimer's disease, dementia, ataxia and myasthenia gravis[1]. | ||||||||||||
| Name | AChE-IN-27 | ||||||||||||
| CAS | 177028-90-9 | ||||||||||||
| Formula | C20H14N2O3 | ||||||||||||
| Molar Mass | 330.34 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Bouazizi Y, et al. Synthesis of new 3, 4-dihydropyrano [c] chromene derivatives and their evaluation as acetyl cholinesterase inhibitors[J]. European Journal of Chemistry, 2014, 5(3): 457-462. |
AChE-IN-27
CAS: 177028-90-9 F: C20H14N2O3 W: 330.34
AChE-IN-27 (compound 8c) is an AChE inhibitor (IC50=0.19 µM). AChE-IN-27 can be used in studies of neurological disease
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.